Skip to main content

  • Top ONE Network news of 2019

    Cataract/Anterior Segment, Comprehensive Ophthalmology, Cornea/External Disease, Glaucoma, Neuro-Ophthalmology/Orbit, Ocular Pathology/Oncology, Oculoplastics/Orbit, Pediatric Ophth/Strabismus, Refractive Mgmt/Intervention, Retina/Vitreous, Uveitis
    Add to My Bookmarks

    From recalls to FDA approvals, here's a look at the year's most-viewed clinical news stories and Editors' Choice coverage.

     

    Headlines

    1. Brolucizumab wins FDA approval, introducing extended dosing for wet AMD

    By Anni Delfaro
    Novartis’ brolucizumab (Beovu) is now FDA-approved for the treatment of wet AMD, the company reported today.
    Oct 09, 2019

    2. FDA approves Rocklatan for open-angle glaucoma, ocular hypertension

    By Keng Jin Lee
    Aerie Pharmaceuticals’ fixed-dose combination of netarsudil and latanoprost has been cleared by the FDA.
    March 13, 2019

    3. Massive Altaire recall sweeps 99 eyecare products off shelves

    By Anni Delfaro
    Altaire Pharmaceuticals has voluntarily recalled 99 ophthalmic products due to potential nonsterility. 
    July 08, 2019

    4. FDA OKs first contact lens to slow childhood myopia

    By Kanaga Rajan
    A contact lens for slowing pediatric myopia progression has received the FDA’s approval, according to manufacturer CooperVision. 
    Nov 19, 2019

    5. Teprotumumab shows robust phase 3 efficacy for thyroid eye disease

    By Kanaga Rajan
    Horizon Pharma announced positive topline results in a confirmatory phase 3 trial evaluating teprotumumab for active thyroid eye disease (TED). 
    Mar 06, 2019

     

    Editors' Choice

    1. Atropine drops effectively control myopia progression

    By Seenu Hariprasad, MD
    This study evaluated the efficacy and safety of low-concentration (0.05%, 0.025% and 0.01%) atropine eye drops compared with placebo over a 1-year period.
    Jan 29, 2019

    2. Topical timolol a viable alternative for resolving ocular pyogenic granulomas

    By Catherine J. Hwang, MD
    This cluster-randomized, intervention-controlled study examined the effect of a school-based program encouraging outdoor activities on myopia.
    Jan 08, 2019

    3. Trifocal vs. extended depth-of-focus IOLs: Which offers better vision outcomes?

    By R. Luke Rebenitsch, MD
    This study compares the performance of 2 diffractive trifocal and 1 extended-depth-of-focus (EDOF) IOLs.
    Aug 31, 2019

    4. Study unveils optimum targeting strategy for trifocal IOLs

    By R. Luke Rebenitsch, MD
    Investigators examined the effect of manifest refraction spherical equivalent error on visual acuity in eyes with trifocal IOLs.
    July 30, 2019

    5. Acute central retinal artery occlusion requires urgent evaluation

    By Sunir J. Garg, MD, FACS; Howard D. Pomeranz, MD, PhD
    The authors evaluated the usefulness of an expedited inpatient evaluation of cerebrovascular risk factors in patients presenting with an acute central retinal artery occlusion (CRAO).
    Dec 20, 2018